A review of the barriers to sharing in biobanking

Biopreservation and Biobanking

Volumn 11, Issue 6, 2013, Pages 339-346

  Colledge, Flora ^a   Elger, Bernice ^a   Howard, Heidi C ^b,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UMR 1027 ^*  (Switzerland)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; BIOBANK; CONFIDENTIALITY; HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; PATENT; PRIORITY JOURNAL; PUBLICATION; REVIEW; BIBLIOGRAPHIC DATABASE; ETHICS; HUMAN; INFORMATION DISSEMINATION; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; PROCEDURES;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; DATABASES, BIBLIOGRAPHIC; HUMANS; INFORMATION DISSEMINATION;

EID: 84890511264     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2013.0039     Document Type: Review

References (56)

1. Cambon-T. A. The social and ethical issues of postgenomic human biobanks. Nat Rev Genet 2004;5:866-873.
2. Day JG, Stacey GN. Biobanking. Mol Biotechnol 2008;40:202-213.
3. Gatter K. Biobanks as a Tissue and Information Semi-Commons: Balancing Interests for Personalized Medicine, Tissue Donors and the Public Health. 2012. Available at: http://works.bepress.com/ken-gatter/1. Accessed 25 November 2013.
4. Finkelstein SN, Sinskey AJ, Cooper SN. Biobanks: Will they help promote the genomics revolution? Pharmaceut Disc 2004;2004.
5. Tansey J, Burgess M. The foundations, applications and ethical dimensions of biobanks. Electronic Working Papers Series. 2004.
6. Oosterhuis JW, Coebergh JW, Van Veen EB. Tumour banks: Well-guarded treasures in the interest of patients. Nature Rev Cancer 2003;3:73-77. (Pubitemid 37328889)
7. Riegman PH, Morente MM, Betsou F, De Blasio P, Geary P. Biobanking for better healthcare. Mol Oncol 2008;2:213-222.
8. Park A. 10 Ideas Changing the World Right Now: Biobanks. Time Mag, April 1, 2009, p. 44
9. Betsou F, et al. What are the biggest challenges and opportunities for biorepositories in the next three to five years? Biopreserv Biobank 2010;8.
10. Ballantyne C. Report urges Europe to combine wealth of biobank data. Nat Med 2008;14:701. (Pubitemid 351951504)
11. Yuille M, Van Ommen GJ, Brechot C, et al. Biobanking for Europe. Brief Bioinform 2008;9:14-24.
12. Asslaber M, Zatloukal K. Biobanks: Transnational, European and global networks. Brief Funct Genomics Proteomics 2007;6:193-201. (Pubitemid 351863876)
13. Pearson H. Summit calls for clear view of deposits in all biobanks. Nature 2004;432:426. (Pubitemid 39576500)
14. Caulfield T, McGuire AL, Cho M, et al. Research ethics recommendations for whole-genome research: Consensus statement. PLoS Biol 2008;6:e73.
15. Hagen HE, Carlstedt-Duke J. Building global networks for human diseases: Genes and populations. Nat Med 2004;10:665-667. (Pubitemid 38937623)
16. Elger BS, Caplan AL. Consent and anonymization in research involving biobanks. Differing terms and norms present serious barriers to an international framework. EMBO Rep 2006;7:661-666. (Pubitemid 43986258)
17. Myles R, Massett HA, Comey G, et al. Stakeholder research on biospecimen needs and reactions to the development of a national cancer human biobank by the national cancer institute. J Natl Cancer Instit Monog 2011:16-23.
18. Hewitt RE. Biobanking: The foundation of personalized medicine. Curr Opin Oncol 2011;23:112-119.
19. Lopez-Guerrero JA, Riegman PH, Oosterhuis JW, et al. TuBa-Frost 4: Access rules and incentives for a European tumour bank. Eur J Cancer 2006;42:2924-2929. (Pubitemid 44755260)
20. Kiehntopf M, Krawczak M. Biobanking and international interoperability: Samples. Hum Genet 2011;130:369-376.
21. Zika E, Paci D, Bruan A, et al. A European survey on biobanks: Trends and issues. Public Health Genomics 2011;14:96-103.
22. Budimir D, Polaasek O, Marusic A, et al. Ethical aspects of human biobanks: A systematic review. Croat Med J 2011;52:262-279.
23. Watson PH, Wilson-McManus JE, Barnes RO, et al. Evolutionary concepts in biobanking-The BC BioLibrary. J Transl Med 2009;7:95.
24. Eiseman E, Bloom G, Brower J, Clancy N, Olmstead S. Case Studies of Existing Human Tissue Repositories:"Best Practices" for a Biospecimen Resource for the Genomic and Proteomic Era. RAND Science and Technology; 2003.
25. Harris JR, Burton P, Knoppers BM, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet 2012;20:1105-1111.
26. Fortin S, Pathmasiri S, Grintuch R,Deschenes M. 'Access arrangements' for biobanks: A fine line between facilitating and hindering collaboration. Public Health Genomics 2011;14:104-114.
27. Kaye J. From single biobanks to international networks: Developing e-governance. Hum Genet 2011;130:377-382.
28. Cambon-T. A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J 2007;30:373-382. (Pubitemid 47194191)
29. Taylor PL. Research sharing, ethics and public benefit. Nat Biotechnol 2007;25:398-401. (Pubitemid 46572836)
30. Joly Y, Knoppers BM. Pharmacogenomic data sample collection and storage: Ethical issues and policy approaches. Pharmacogenomics 2006;7:219-226.
31. Kaye J. Do we need a uniform regulatory system for biobanks across Europe? Eur J Human Genet 2006;14:245-248. (Pubitemid 43135869)
32. van Veen EB, Rugman PH, Dinjens WN, et al. TuBaFrost 3: Regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 2006;42:2914-2923. (Pubitemid 44767664)
33. Boggio A, Biller-Andorno N, Elger B, Mauron A, Capron AM. Comparing guidelines on biobanks: Emerging consensus and unresolved controversies. 2005. Geneva, Switzerland: Réseau Universitaire International de Genève.
34. Hewitt R, Hainaut P. Biobanking in a fast moving world: An international perspective. J Natl Cancer Inst Monogr 2011:50-51.
35. Chokshi DA, Parker M,Kwiatkowski DP. Data sharing and intellectual property in a genomic epidemiology network: Policies for large-scale research collaboration. Bull World Health Org 2006;84:382-387.
36. Shickle D, Griffin M,El-Arifi K. Inter-and intra-biobank networks: Classification of biobanks. Pathobiology 2010;77:181-190.
37. Cambon T. A. Assessing the impact of biobanks. Nat Genet 2003;34:25-26.
38. Gibbons SMC. Regulating biobanks: A twelve-point typological tool. Med Law Rev 2009;17:313-346.
39. Salvaterra E, Lecchi L, Giovanelli S, et al. Banking together-A unified model of informed consent for biobanking. EMBO Rep 2008;9:307-313.
40. Stjernschantz F. J, Hansson MG,Eriksson S. Biobank research: Who benefits from individual consent? BMJ 2011;343: d5647.
41. Steinbekk KS. Biobank. When is re-consent necessary? Public Health Ethics 2011;4:236-250.
42. Forsberg JS, Hansson MG,Eriksson S. The risks and benefits of re-consent. Science 2011;332:306; author reply 306.
43. Budin-Ljosne I, Tasse AM, Knoppers BM,Harris JR. Bridging consent: From toll bridges to lift bridges? BMC Med Genomics 2011;4:69.
44. Goebel JW, Packardt T, Bedau M, et al. Legal and ethical consequences of international biobanking from a national perspective: The German BMB-EUCoop project. Eur J Human Genet 2010;8:522-525.
45. Morente MM, Alonso S. Current challenges of human tumour banking. Hematol Oncol 2005;23:54-56. (Pubitemid 41774986)
46. Shaw PM, Patterson SD. The value of banked samples for oncology drug discovery and development. J Natl Cancer Inst Monogr 2011;46-49.
47. Andersson K, Bray F, Aabyn M, et al. The interface of population-based cancer registries and biobanks in etiological and clinical research-Current and future perspectives. Acta Oncol 2010;49:1227-1234.
48. Otto M, Bowser R, Turner M, et al. Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler 2012; 3:1-10.
49. Simon BM. How to get a fair share: IP policies for publicly supported biobanks. Stanford J Law Sci Policy 2009;1:66-79.
50. Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 2006;7:266-269. (Pubitemid 43286456)
51. Tomlinson T. Respecting donors to biobank research. Hastings Cent Rep 2013;43:41-47.
52. Steinsbekk KS, Kare Myskja B, Solberg B. Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem? Eur J Hum Genet 2013;21:897-902.
53. Kaye J, Heeney C, Hawkins N, De Vries J,Boddington P. Data sharing in genomics-Re-shaping scientific practice. Nat Rev Genet 2009;10:331-335.
54. Knoppers BM, Harris JR, Tasse AM, et al. Towards a data sharing Code of Conduct for international genomic research. Genome Med 2011;3:46.
55. Baust JG. A crisis in biobaking. Cell Preserv Technol 2005;3:1-2.
56. Scott CT, Caulfield T, Borgelt E, Illes J. Personal medicine-The new banking crisis. Nature Biotechnol 2012;30:141-147.